Opinion
A sports device to ‘protect the brain’ illustrates a major problem with the FDA de novo pathway
This is not just about one device. It’s about what happens when institutions grow comfortable living in their own ambiguity and hiding behind opacity.” ...
A month’s supply of Miebo requires $800 and a prescription in the U.S. In Europe, it’s over-the-counter and $20.
It is evolutionarily certain that we will have more outbreaks, more pandemics, and frankly, they could be significantly worse ...
Medicare on Friday followed through with its earlier proposal to reduce payment for surgeries, outpatient procedures, and other services it believes can be done more efficiently starting in 2026.
Health care has become a central issue in this year’s elections, a sign of parties' midterm strategies to come.
Dozens of scientists are considering leaving the Center for Biologics Evaluation and Research, where Prasad serves as ...
The crises at the heart of the government shutdown fight in Washington were coming to a head Saturday as the federal food assistance ...
Officials from Colorado, Illinois, Oregon, and Washington say CMS Administrator Mehmet Oz posted incorrect figures about their Medicaid spending on X.
Merck, which has claimed bragging rights as the maker of the world’s best-selling drug, Keytruda, since 2023, has officially ...
A bidding war has broken into the open for the obesity-focused Metsera, with Novo Nordisk aiming to outbid Pfizer for the ...
Judges order the Trump administration to use contingency funds for SNAP payments during the shutdown
Two federal judges ruled nearly simultaneously on Friday that President Trump’s administration must to continue to fund SNAP ...
NIH-led research on structural racism was published Friday, even as the Trump administration has cancelled and discredited ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results